Open Net Zero logo
Adverse Outcome Pathway Network-Based Assessment of the Interactive Effects of an Androgen Receptor Agonist and an Aromatase Inhibitor on Fish Endocrine Function
L o a d i n g
Organization
United State Environmental Protection Agency - view all
Update frequencyunknown
Last updatedover 2 years ago
Format
Overview

Adverse outcome pathway (AOP) networks potentially provide a basis for predictive approaches to assess the toxicity of chemical mixtures. This study evaluated the utility of a simple AOP network to predict the interactive effects of a binary chemical mixture comprised of an inhibitor of the aromatase enzyme (fadrozole, a human pharmaceutical) and an agonist of the androgen receptor (trenbolone, a veterinary drug). Overall, prediction of interactive effects of the two chemicals based on the AOP network did not match actual observed effects. Rather, the two compounds seemed to interact in an independent manner in terms of their effects on the hypothalamic-pituitary-gonadal axis in the fish. This dataset is associated with the following publication: Ankley, G., B. Blackwell, J. Cavallin, J. Doering, D.J. Feifarek, K. Jensen, M. Kahl, C. Lalone, S. Poole, E. Randolph, T. Saari, and D. Villeneuve. Adverse outcome pathway network-based assessment of the interactive effects of an androgen receptor agonist and an aromatase inhibitor on fish endocrine function. AQUATIC TOXICOLOGY. Elsevier Science Ltd, New York, NY, USA, 39(4): 913-922, (2020).

17-beta-trenboloneadverse outcome pathwayandrogen receptoraquatic ecosystemsaromatase inhibitorecotoxicologyendocrine disruptionfadrozolefathead minnowscreening and prioritization
Additional Information
KeyValue
Dcat Modified2019-07-17
Dcat Publisher NameU.S. EPA Office of Research and Development (ORD)
Guidhttps://doi.org/10.23719/1504080
Share this Dataset
Trust Signals
Trust Framework(s)None
Assuranceunknown
Data Sensitivity Classunknown
Licenceunknown
Files
  • 21792b28-1f9d-4c0e-8bd1-dca2bb3b2c5f